ArticleOpen medicine (Warsaw, Poland)2021

Pemetrexed-based first-line chemotherapy had particularly prominent objective response rate for advanced NSCLC: A network meta-analysis.

Yuankai Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.